A randomized study of consolidation chemo-radiotherapy versus observation after first-line chemotherapy in advanced gall bladder cancers (RACE-GB Study): trial protocol

Authors

  • Sushma Agrawal Department of Radiotherapy SGPGI, Lucknow, Uttar Pradesh, India
  • Ashish Singh Department of Surgical Gastroenterology, SGPGI, Lucknow, Uttar Pradesh, India
  • Rahul Department of Surgical Gastroenterology, SGPGI, Lucknow, Uttar Pradesh, India https://orcid.org/0000-0001-7690-6704
  • Prabhakar Mishra Department of Biostatistics, SGPGI, Lucknow, Uttar Pradesh, India
  • Rajan Saxena Department of Surgical Gastroenterology, SGPGI, Lucknow, Uttar Pradesh, India https://orcid.org/0000-0002-3122-0140

DOI:

https://doi.org/10.18203/2349-3259.ijct20230055

Keywords:

Advanced gallbladder cancer, First line chemotherapy, Responders, Consolidation chemoradiation

Abstract

Background: Chemotherapy (CT) is the standard of care for advanced gall bladder cancer (GBC). However, after completion of 6 cycles of CT, a proportion of patients with good performance status progress within a few months. Retrospective data in locally advanced cases revealed that consolidation chemo-radiotherapy (CTRT) in responders to CT and with good performance status improves overall survival.

Methods: FNA proven advanced GBC with predefined clinical-radiological features will be administered 4 cycles CT (cisplatin-gemcitabine combination). After completion of CT, those in good Karnofsky performance status (KPS) will be randomised to consolidation CTRT versus observation (standard of care). The primary end point of the study is to compare OS between the two arms. The secondary end point is to compare progression free survival (PFS), toxicity, and quality of life between the two study arms. The trial is designed to detect an improvement in 2-year overall survival (OS) from 8% in the control arm to 25% in study arm with 80.0% power at a 0.05 significance level. The resultant sample size to achieve this aim is 140 (70 in each arm) over a duration of 4-5 years with a 10% attrition rate. Accrual has been from January 2019 to October 2022.

Conclusions: This trial aims to assess the incremental gain in outcomes with consolidation CTRT versus observation in responders to first-line CT in advanced GBCs. This is the first randomised study to evaluate role of consolidation chemoradiation.

Trial Registration: The trial is registered with clinical trials registry India (CTRI/2019/04/025204) and clinical trials.gov (NCT05493956).

Author Biographies

Sushma Agrawal, Department of Radiotherapy SGPGI, Lucknow, Uttar Pradesh, India

Professor, Radiotherapy

Ashish Singh, Department of Surgical Gastroenterology, SGPGI, Lucknow, Uttar Pradesh, India

Associate Profesor

Surgical Gastroenterology

Rahul, Department of Surgical Gastroenterology, SGPGI, Lucknow, Uttar Pradesh, India

Associate Professor

Surgical Gastroenterology

Prabhakar Mishra, Department of Biostatistics, SGPGI, Lucknow, Uttar Pradesh, India

Additional Professor, Biostatistics

Rajan Saxena, Department of Surgical Gastroenterology, SGPGI, Lucknow, Uttar Pradesh, India

Professor, Surgical Gastroenterology

References

Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide:geographical distribution and risk factors. Int J Cancer. 2006;118:1591-602.

Valle J,Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, et al. ABC-02 Trial Investigators. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273-81.

Agrawal S, Mohan L, Mourya C, Neyaz Z, Saxena R. Radiological downstaging with neoadjuvant therapy in unresectable gall bladder cancer cases. Asian Pac J Cancer Prev. 2015;17(4):2137-40.

Engineer R, Goel M, Chopra S, Patil P, Purandare N, Rangarajan V, et al. Neoadjuvant chemoradiation followed by surgery for locally advanced gallbladder cancers: a new paradigm. Ann Surg Oncol. 2016; 23(9):3009-15.

Sharma M, Talwar V, Maheshwari U, Koyyala VPB, Goel V, Goyal S, et al. Role of Maintenance Gemcitabine in Advanced Carcinoma Gallbladder. South Asian J Cancer. 2020 Oct;9(4):204-8.

Sinha S, Engineer R, Ostwal V, Ramaswamy A, Chopra S, Shetty N. Radiotherapy for locally advanced unresectable gallbladder cancer - A way forward: Comparative study of chemotherapy versus chemoradiotherapy. J Can Res Ther 2022;18:147-51.

Agrawal S, Alam N, Rastogi N, Das KJ. Consolidation Chemo-radiation improves survival in responders to first line chemotherapy (CT) in Locally advanced GBC (LA-GBC). J Global Oncol. 2019;5: 97.

Agrawal S, Gupta PK, Rastogi N, Lawrence A, Kumari N, Das KJ, Saxena R. Outcomes of adjuvant chemoradiation and predictors of survival after extended cholecystectomy in gall bladder carcinoma: a single institution experience from an endemic region. J Gastrointest Cancer. 2015;46(1):48-53.

Downloads

Published

2023-01-23